ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Prostate Cancer trials near Columbus, OH, USA:

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

and with darolutamide in men with metastatic castration-resistant prostate cancer. The study aims to assess whether the drug is saf ...

Enrolling
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Metastatic Castration-resistant Prostate Cancer, mCRPC
Drug: KTX-2001
Drug: KTX-2001 + Darolutamide (NUBEQA®)

Phase 1

K36 Therapeutics

Columbus, Ohio, United States and 13 other locations

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Columbus, Ohio, United States and 35 other locations

The primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered as monotherapy or in combination with an...

Enrolling
Prostate Cancer
Drug: GnRH Antagonist
Drug: Xaluritamig

Phase 1

Amgen
Amgen

Columbus, Ohio, United States and 8 other locations

practice to see if FK-PC101 works to prevent or delay the return of prostate cancer following surgery to remove the prostate...

Enrolling
Prostate Cancer (Post Prostatectomy)
Prostate Cancers
Biological: Standard of Care (SOC)
Biological: FK-PC101

Phase 2

Cellvax Therapeutics Inc

Gahanna, Ohio, United States and 2 other locations

clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Other: ADT
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 2

Bayer
Bayer

Gahanna, Ohio, United States and 32 other locations

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 341 other locations

The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Xaluritamig
Drug: Docetaxel

Phase 3

Amgen
Amgen

Columbus, Ohio, United States and 148 other locations

study is focused on participants with previously treated metastatic prostate cancer.The main purpose of the study is to look at the...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: REGN5678
Drug: REGN4336

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Columbus, Ohio, United States and 12 other locations

This phase II trial compares the effect of relugolix to leuprolide on cardiac function and performance in patients with prostate cancer...

Enrolling
Prostate Adenocarcinoma
Stage IIC Prostate Cancer AJCC v8
Drug: Relugolix
Other: Contrast Agent

Phase 2

The Ohio State University
The Ohio State University

Columbus, Ohio, United States

Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...

Active, not recruiting
Metastasis From Malignant Tumor of Prostate
Drug: 177Lu-PSMA-I&T
Drug: Abiraterone with Prednisone or Enzalutamide

Phase 3

Curium

Gahanna, Ohio, United States and 51 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems